Document Detail

MedLine Citation:
PMID:  23022763     Owner:  NLM     Status:  Publisher    
Esthesioneuroblastoma is an uncommon malignancy originating from olfactive epithelium. Men are more frequently affected than women. Nasal symptoms are the most common revealing signs. Immunohistochemistry helps diagnosis. There is no randomized trial evaluating treatment due to the low incidence of this tumor. Radiotherapy and surgery are the standard of care. Radiotherapy is benefic even in early stage disease. Chemotherapy is indicated in case of locally advanced or metastatic disease.
Fatma Elloumi; Noureddine Boujelbene; Lilia Ghorbal; Nadia Boujelbene; Khaouthar Khanfir; René-Olivier Mirimanoff; Jamel Daoud
Related Documents :
20664593 - Identification of biological factors predictive of response to imatinib mesylate in agg...
24857583 - Adrenocortical cancer update.
19012213 - Pulmonary resection of non-small cell lung cancer: is survival in the elderly not affec...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-10-1
Journal Detail:
Title:  Bulletin du cancer     Volume:  -     ISSN:  1769-6917     ISO Abbreviation:  Bull Cancer     Publication Date:  2012 Oct 
Date Detail:
Created Date:  2012-10-1     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0072416     Medline TA:  Bull Cancer     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Centre hospitalier universitaire Habib Bourguiba, service de radiothérapie carcinologique, route el Aïn Km 0.5, 3029 Sfax, Tunisie.
Vernacular Title:
Les esthésioneuroblastomes<!---->
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Ruptured aneurysm of the popliteal artery. Is the diagnosis still difficult.
Next Document:  Of blood cells and the nervous system: hematopoiesis in the Drosophila larva.